[DISCUSSION] MODULE 2: QUIZ 2 COVERAGE Flashcards

(108 cards)

1
Q

1961: Till and McCulloch

- irradiated [?] and [?] of mice = aplasia

A

spleens and BM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

1961: Till and McCulloch

- Aplastic mice given IV injection of

A

BM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

1961: Till and McCulloch

- Colonies of HSCs were seen [?] later in the spleens

A

7-8 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1961: Till and McCulloch

- Colonies =

A

Colony Forming Unit-Spleen (CFU-S)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Capable of self renewal and production of differentiated progeny

A

Colony Forming Unit-Spleen (CFU-S)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

“committed myeloid progenitors”

A

colony forming unit granulocyte, erythrocyte, monocyte, megakaryocyte “CFU-GEMM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

capable of giving rise to multiple lineages of blood cells

A

Colony Forming Unit-Spleen (CFU-S)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HEMATOPOIETIC PROGENITOR CELLS

2 Major types

A

I. Noncommitted/Undifferentiated hematpoietic stem cells (HSCs)
II. Committed projenitor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HEMATOPOIETIC PROGENITOR CELLS (committed and noncommitted) give rise to

A

all of the mature blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 Theories of Hematopoietic Progenitor cell origin

A
  1. Monophyletic theory

2. Polyphyletic theory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pluripotent hematopoietic stem cell

A

Monophyletic theory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Most widely accepted theory

A

Monophyletic theory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

vCapable of self-renewal

A

HEMATOPOIETIC STEM CELLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

vAre pluripotent

A

HEMATOPOIETIC STEM CELLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

vGive rise to diff progeny

A

HEMATOPOIETIC STEM CELLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

vAble to reconstitute the hematopoietic system of a lethally irradiated host

A

HEMATOPOIETIC STEM CELLS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Can differentiate into progenitor cells committed to either lymphoid or myeloid lineages

A

UNDIFFERENTIATED HSCS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Proliferates and Differentiates into: T, B, natural killer lymphocyte, dendritic cells

A

Common lymphoid progenitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Proliferates and differentiates into: individual granulocytic, erythrocytic, monocytic and megakaryocytic lineages

A

Common myeloid progenitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

FATES OF HSCS

A
  1. Self-renewal
  2. Differentiation
  3. Apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When the HSC divide, it gives rise to two identical daughter cells

A

a. Symmetric division

b. Asymmetric division

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

**Till and Mculloch: Proposed that hematopoiesis is a random process whereby the JSC randomly commits to self-renewal or differentiation

A

STOCHASTIC model of hematopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Later studies suggest that the microenvironment in the BM determines whether the HSC will sef-renew or differentiate

A

INSTRUCTIVE model of hematopoiesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Current thinking suggests that the ultimate decision made by the HSC can be describes by both

A

stochastic and instructive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Initial decision to self renew is probably
stochastic
26
which occurs later is determined by various signals from the HIM in response to spp requirements of the body
Lineage differentiation
27
parent cell produces identical cells with identical chromosomes; chromosomes are visible with light microscope
Mitotic phase
28
-Cytoplasm and nucleus mature at the same rate
1. Synchronous
29
-Cytoplasm or nucleus mature first before the other Can lead to abnormality in shape and size
2. Asynchronous
30
1. Blast cells do not have
granules
31
2. Blast cells contain a (?) ([?] to [?] of cell area) and a (?)
large nucleus - 3/3 to 7/8 | small amount of cytoplasm
32
3. As cells mature, the cytoplasm becomes
less basophilic
33
``` 4. As cells mature, the (?) of the nucleus becomes heavier, and the darker the (?) stains, the heavier the chromatin is ```
chromatin | nucleus
34
5. As the cells mature, they become
smaller
35
6. (?) tend to disappear in mature cells
Nucleoli
36
7. As cells mature, specific granules become
less prominent and smaller
37
8. There are 4 different types of granules:
neutrophilic, basophilic, eosinophilic, azurophilic (primary)
38
-Group of specific glycoproteins secreted by cells
Cytokine
39
-in Hematopoiesis, they regulate the proliferation, differentiation, and maturation of hematopoietic precursor cells (include: IL, lymphokines, monokines, interferons, chemokines, colony stimulating factors)
Cytokine
40
•Have direct and indirect effects on hematopoietic cells
CYTOKINES OR GROWTH FACTORS
41
•Cytokines with a positive influence on hematopoietic stem cells and progenitor cells with multilineage potential
KIT ligand, FLT3 ligand, GM-CSF, IL-1, 6, 11
42
KIT ligand, FLT3 ligand, GM-CSF, IL-1, IL-6, IL-11
Cytokines with a positive influence on hematopoiesis
43
Cytokines with a negative influence on hematopoiesis
Transforming growth factor-B, Tumor necrosis factor-a, interferons
44
Cytokines with multiple actions
Interleukins
45
a. Proteins exhibiting
multiple biologic activities
46
b. Have [?] with other cytokines
synergistic interactions
47
c. Part of interacting systems with [?]
amplification potential
48
d. effective at
very low concentrations
49
-have high specificity for their target cells
Colony Stimulating Factors (CSF)
50
-active at low concentrations
Colony Stimulating Factors (CSF)
51
Can be classified accdg to the part of the development process that they influence
Growth Factors
52
Multilineage in action
Early acting growth factors
53
Ex: KIT ligand, FLT3 Ligand, GM-CSF, IL-3
Early acting growth factors
54
formerly erythrocytes
RBCs
55
Erythroblasts
nucleated red cell precursors
56
Normoblasts
developing nucleated cells with normal appearance
57
Megaloblast
abnormal appearance of developing nucleated cells in megaloblastic anemia
58
Three nomenclatures are used in naming for the erythroid precursors
NORMOBLASTIC RUBRIBLASTIC ERYTHROBLASTIC
59
-The glycoprotein hormone produced by the kidneys (renal peritubular interstitial cells)
ERYTHROPOIETIN
60
-ERYTHROPOIETIN Main effect:
Place more erythrocytes into the circulation at a faster rate
61
Main effect: Place more erythrocytes into the circulation at a faster rate. HOW?
1. Early release of reticulocytes 2. Prevent apoptotic cell death 3. Reduces maturation time inside the bone marrow
62
MATURATION SEQUENCE
I. Erythroid progenitors | II. Erythroid Precursors
63
I. Erythroid progenitors
a. Pluripotential hematopoietic stem cells b. CFU-GEMM/CFU-S c. CFU-MegE d. BFU-E d. CFU-E
64
II. Erythroid Precursors
a. Pronormoblast b. Basophilic normoblast c. Polychromatic normoblast d. Orthochromic normoblast e. Reticulocyte/Polychromatic (polychromatophilic) erythrocyte f. Erythrocyte
65
is a process encompassing replication (division) to increase cell numbers and development from immature to mature cell stages.
Normoblastic proliferation
66
Period between cell divisions; chromosomes not visible under the light microscope
Interphase
67
Limbo phase; Cells that are not dividing and possibly never to divide again
G0 phase
68
Metabolically active cell duplicates most of its organelles and cytosolic components
G1 phase (8-10 hours)
69
Replication of chromosome begins
G1 phase (8-10 hours)
70
Replication of DNA and chromosomes
S phase (8 hours)
71
Cell growth, enzyme and protein synthesis continue
G2 phase (4-6 hours)
72
Replication of centrosome complete
G2 phase (4-6 hours)
73
Parent cell produces identical cells with identical chromosomes; chromosomes visible under the light microscope
Mitotic Phase
74
▪ Nuclear division
Mitosis
75
▪ Distribution of two sets of chromosomes into separate nuclei
Mitosis
76
Chromatin fibers condense into paired chromatids
Prophase
77
Nucleolus and nuclear envelope disappear
Prophase
78
Each centrosome moves to an opposite pole of the cell
Prophase
79
Centromeres of chromatid pairs line up at the metaphase plate
Metaphase
80
Centromeres split
Anaphase
81
Identical sets of chromosomes move to opposite poles of cell
Anaphase
82
Nuclear envelopes and nucleoli reappear
Telophase
83
Chromosome resume chromatin form
Telophase
84
Mitotic spindle disappears
Telophase
85
▪ Cytoplasmic division
Cytokinesis
86
▪ Usually begins in late anaphase with the formation of a cleavage furrow & is completed after the telophase
Cytokinesis
87
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
EPO
88
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
G-CSF
89
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
GM-CSF
90
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IL-2
91
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IL-3
92
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IL-6
93
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IL-10
94
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IL-12
95
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IL-15
96
Primary Cell Source: Primary Target Cell: Biological Activity: Current/Potential Therapeutic Applications:
IFN-a
97
-Stimulus to red cell production
Hypoxia
98
Primary oxygen sensing system
kidneys (peritubular fibroblasts)
99
Hypoxia = detected by [?] which release EPO
peritubular cells
100
detected by peritubular cells which release EPO
Hypoxia
101
They receive 20% of cardiac output with little loss of O2 levels leaving the heart = early detection of oxygen level decline
kidneys
102
Regardless of the source of hypoxia, having more [?] should help to overcome it.
red blood cells
103
A true hormone
Erythropoietin – EPO
104
Produced at the kidneys
Erythropoietin – EPO
105
Acting at a distant location (the bone marrow)
Erythropoietin – EPO
106
A growth factor that initiates an intracellular message to the developing red cells = SIGNAL TRANSDUCTION
EPO
107
**EPO must bind to its [?] to initiate the signal or the message.
receptor on the surface of the cells
108
Criteria used in the ID of the erythroid precursors: | Trends affecting the red cell appearance throughout maturation:
1. Overall diameter of the cell decreases 2. Diameter of the nucleus decreases l=more rapidly than does the size of the cell = N:C ratio decreases 3. Nuclear chromatin becomes coarser, clumped, condensed 4. Nucleoli disappear